Is being positive for HBsAg, HBeAb, and HBcAb considered "minor three positives"?
The results of the hepatitis B panel showing positivity for items 1, 4, and 5 indicate what is commonly known as "minor three positive" (HBeAb-positive chronic HBV infection).
The five components of the hepatitis B panel are: hepatitis B surface antigen (HBsAg), hepatitis B surface antibody (HBsAb), hepatitis B e-antigen (HBeAg), hepatitis B e-antibody (HBeAb), and hepatitis B core antibody (HBcAb). When test results show positivity for items 1, 4, and 5—meaning HBsAg, HBeAb, and HBcAb are all positive—it indicates that the individual is a carrier of the hepatitis B virus, typically with low viral activity, commonly referred to as "minor three positive." If a person has the "minor three positive" pattern, normal liver function, no subjective symptoms, and no abnormalities in liver histology, they are considered a hepatitis B virus carrier. However, antiviral treatment is required if liver function is abnormal—such as elevated alanine aminotransferase (ALT) and aspartate aminotransferase (AST)—along with positive HBV-DNA quantitative results or inflammatory changes in liver histology.
Patients with "minor three positive" hepatitis B should quit smoking and avoid alcohol, use medications appropriately, and develop healthy lifestyle habits. Alcohol can cause significant liver damage; therefore, patients with this condition must abstain from drinking completely.